- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Correction to: Relugolix: A Review in Advanced Prostate Cancer ; volume:18 ; number:4 ; day:18 ; month:5 ; year:2023 ; pages:637 ; date:7.2023
Targeted oncology ; 18, Heft 4 (18.5.2023), 637, 7.2023
- Urheber
-
Shirley, Matt
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11523-023-00977-3
- URN
-
urn:nbn:de:101:1-2023101809214556270610
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shirley, Matt
- SpringerLink (Online service)
Ähnliche Objekte (12)
Hormonal treatment of advanced prostate cancer
Correction to: Darolutamide: A Review in Metastatic Hormone-Sensitive Prostate Cancer
Treatment of locally advanced prostate cancer: a case report and narrative review
Correction to: Durvalumab: A Review in Advanced Biliary Tract Cancer
Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer
Correction to: Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
Pilot Study: PARP1 Imaging in Advanced Prostate Cancer
The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence
The role of cystoprostatectomy in management of locally advanced prostate cancer: a systematic review
Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer
Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer
Hormonal treatment of advanced prostate cancer
Correction to: Darolutamide: A Review in Metastatic Hormone-Sensitive Prostate Cancer
Treatment of locally advanced prostate cancer: a case report and narrative review
Correction to: Durvalumab: A Review in Advanced Biliary Tract Cancer
Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer
Correction to: Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
Pilot Study: PARP1 Imaging in Advanced Prostate Cancer
The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence
The role of cystoprostatectomy in management of locally advanced prostate cancer: a systematic review
Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer
Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer
Hormonal treatment of advanced prostate cancer
Correction to: Darolutamide: A Review in Metastatic Hormone-Sensitive Prostate Cancer
Treatment of locally advanced prostate cancer: a case report and narrative review
Correction to: Durvalumab: A Review in Advanced Biliary Tract Cancer
Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer
Correction to: Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
Pilot Study: PARP1 Imaging in Advanced Prostate Cancer
The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence
The role of cystoprostatectomy in management of locally advanced prostate cancer: a systematic review
Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer